Report cover image

Reporter Gene Assay

Publisher Global Industry Analysts
Published Apr 01, 2023
Length 88 Pages
SKU # GJOB17890773

Description

Reporter Gene Assay

Global Reporter Gene Assay Market to Reach $11.5 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Reporter Gene Assay estimated at US$7.9 Billion in the year 2022, is projected to reach a revised size of US$11.5 Billion by 2030, growing at aCAGR of 4.8% over the period 2022-2030. Luciferase Assays, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$4.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Fluorescent Protein-Related Assays segment is readjusted to a revised 5.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 4.2% CAGR
The Reporter Gene Assay market in the U.S. is estimated at US$2.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2030 trailing a CAGR of 4.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 3.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Select Competitors (Total 32 Featured) -

  • Abcam PLC
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Biotium
  • Danaher Corporation
  • Genecopoeia, Inc.
  • Geno Technology, Inc.
  • Invivogen
  • Merck KGaA
  • Perkinelmer
  • Promega Corporation
  • Promocell
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Table of Contents

88 Pages
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Reporter Gene Assay – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Reporter Gene Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 2: World 8-Year Perspective for Reporter Gene Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
TABLE 3: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 4: World 8-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 5: World Reporter Gene Assay Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 6: World Recent Past, Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 7: World 8-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 9: World 8-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 11: World 8-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 13: World 8-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for In-vitro Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 15: World 8-Year Perspective for In-vitro Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Luciferase Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 17: World 8-Year Perspective for Luciferase Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Fluorescent Protein-Related Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 19: World 8-Year Perspective for Fluorescent Protein-Related Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Chloramphenicol Acetyltransferase Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 21: World 8-Year Perspective for Chloramphenicol Acetyltransferase Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Beta-Galactosidase Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 23: World 8-Year Perspective for Beta-Galactosidase Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 24: World Recent Past, Current & Future Analysis for Beta-Glucuronidase Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 25: World 8-Year Perspective for Beta-Glucuronidase Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 27: World 8-Year Perspective for Other Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
TABLE 28: USA Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 29: USA 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 30: USA Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 31: USA 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 33: USA 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
CANADA
TABLE 34: Canada Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 35: Canada 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 36: Canada Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 37: Canada 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 39: Canada 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
JAPAN
Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
TABLE 40: Japan Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 41: Japan 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 42: Japan Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 43: Japan 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 45: Japan 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
CHINA
Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
TABLE 46: China Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 47: China 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 48: China Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 49: China 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 50: China Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 51: China 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
EUROPE
Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
TABLE 52: Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 53: Europe 8-Year Perspective for Reporter Gene Assay by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
TABLE 54: Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 55: Europe 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 57: Europe 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 58: Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 59: Europe 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
FRANCE
Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
TABLE 60: France Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 61: France 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 62: France Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 63: France 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 64: France Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 65: France 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
GERMANY
Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
TABLE 66: Germany Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 67: Germany 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 68: Germany Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 69: Germany 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 70: Germany Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 71: Germany 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
ITALY
TABLE 72: Italy Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 73: Italy 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 74: Italy Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 75: Italy 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 76: Italy Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 77: Italy 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
UNITED KINGDOM
Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
TABLE 78: UK Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 79: UK 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 80: UK Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 81: UK 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 82: UK Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 83: UK 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
REST OF EUROPE
TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 85: Rest of Europe 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 87: Rest of Europe 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 89: Rest of Europe 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
ASIA-PACIFIC
Reporter Gene Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 91: Asia-Pacific 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 93: Asia-Pacific 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 95: Asia-Pacific 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
REST OF WORLD
TABLE 96: Rest of World Recent Past, Current & Future Analysis for Reporter Gene Assay by Product Type - Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 97: Rest of World 8-Year Perspective for Reporter Gene Assay by Product Type - Percentage Breakdown of Value Sales for Luciferase Assays, Fluorescent Protein-Related Assays, Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase Assays, Beta-Glucuronidase Assays and Other Assays for the Years 2023 & 2030
TABLE 98: Rest of World Recent Past, Current & Future Analysis for Reporter Gene Assay by End-Use - Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 99: Rest of World 8-Year Perspective for Reporter Gene Assay by End-Use - Percentage Breakdown of Value Sales for Contract Research Organizations (CROs), Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2023 & 2030
TABLE 100: Rest of World Recent Past, Current & Future Analysis for Reporter Gene Assay by Application - Clinical and In-vitro Studies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 101: Rest of World 8-Year Perspective for Reporter Gene Assay by Application - Percentage Breakdown of Value Sales for Clinical and In-vitro Studies for the Years 2023 & 2030
IV. COMPETITION

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us